Prestige Consumer Healthcare Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Prestige Consumer Healthcare Inc 公司

Prestige Consumer Healthcare Inc. 是一家消费者保健产品公司。该公司从事非处方 (OTC) 健康和个人护理产品的开发、制造、营销、销售和分销，面向北美（美国和加拿大）和澳大利亚以及其他某些国际市场的大众零售商、药店、食品店、便利店、俱乐部和电子商务商店。该公司通过两个部门运营：北美 OTC 医疗保健部门和国际 OTC 医疗保健部门。其多元化的品牌组合包括 Monistat 和 Summer's Eve 女性保健产品、BC 和 Goody's 止痛药、Clear Eyes 和 TheraTears 眼部护理产品、DenTek 专业口腔护理产品、Dramamine 晕动病治疗产品、Fleet 灌肠剂和甘油栓剂、Chloraseptic 和 Luden's 咽喉痛治疗产品和滴剂、Compound W 疣去除产品、Boudreaux's Butt Paste 尿布疹软膏、Nix 虱子治疗产品、Debrox 耳垢清除剂等。

Prestige Consumer Healthcare Inc简介



公司代码PBH

公司名称Prestige Consumer Healthcare Inc

上市日期Feb 10, 2005

CEOMr. Ronald M. (Ron) Lombardi, CPA

员工数量600

证券类型Ordinary Share

年结日Feb 10

公司地址660 White Plains Rd.

城市TARRYTOWN

上市交易所NYSE Consolidated

国家United States of America

邮编10591

电话19145246800

网址https://www.prestigebrands.com/

公司代码PBH

上市日期Feb 10, 2005

CEOMr. Ronald M. (Ron) Lombardi, CPA

Prestige Consumer Healthcare Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Ronald M. (Ron) Lombardi, CPA

Chairman of the Board, President, Chief Executive Officer

355.35K

-10.40%

Ms. Christine (Chris) Sacco, CPA

Chief Financial Officer, Chief Operating Officer

63.23K

-32.80%

Mr. John E. Byom

Lead Independent Director

52.39K

+4.16%

Mr. William C. P'Pool, J.D.

Senior Vice President, General Counsel, Corporate Secretary

35.30K

+10.28%

Mr. Jeffrey Zerillo

Senior Vice President - Operations

35.20K

+6.66%

Ms. Sheila A. Hopkins

Independent Director

27.92K

+8.11%

Mr. Adel Mekhail

Executive Vice President - Marketing & Sales

15.16K

-30.95%

Ms. Dawn M. Zier

Independent Director

14.33K

+17.11%

Dr. Celeste A. Clark, Ph.D.

Independent Director

11.33K

+22.68%

Mr. James C. D'arecca

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Ronald M. (Ron) Lombardi, CPA

Chairman of the Board, President, Chief Executive Officer

355.35K

-10.40%

Ms. Christine (Chris) Sacco, CPA

Chief Financial Officer, Chief Operating Officer

63.23K

-32.80%

Mr. John E. Byom

Lead Independent Director

52.39K

+4.16%

Mr. William C. P'Pool, J.D.

Senior Vice President, General Counsel, Corporate Secretary

35.30K

+10.28%

Mr. Jeffrey Zerillo

Senior Vice President - Operations

35.20K

+6.66%

Ms. Sheila A. Hopkins

Independent Director

27.92K

+8.11%

收入明细

单位: USD更新时间: 10月6日周一

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

暂无数据

地区USD

名称

营收

占比

United States

897.54M

78.89%

Rest of world

240.22M

21.11%

业务

地区

暂无数据

股东统计

更新时间: 10月17日周五

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

14.62%

The Vanguard Group, Inc.

11.40%

Dimensional Fund Advisors, L.P.

5.14%

Ariel Investments, LLC

4.58%

State Street Investment Management (US)

4.16%

其他

60.10%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

14.62%

The Vanguard Group, Inc.

11.40%

Dimensional Fund Advisors, L.P.

5.14%

Ariel Investments, LLC

4.58%

State Street Investment Management (US)

4.16%

其他

60.10%

股东类型

持股股东

占比

Investment Advisor

66.27%

Investment Advisor/Hedge Fund

30.99%

Research Firm

3.47%

Hedge Fund

1.89%

Pension Fund

1.33%

Individual Investor

1.29%

Sovereign Wealth Fund

1.12%

Family Office

0.61%

Bank and Trust

0.53%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

667

52.11M

108.37%

-2.03M

2025Q2

667

53.74M

109.15%

-2.00M

2025Q1

670

54.01M

109.68%

-1.79M

2024Q4

653

54.79M

110.61%

+365.71K

2024Q3

633

53.04M

107.02%

-1.71M

2024Q2

622

53.11M

106.92%

-2.21M

2024Q1

614

53.06M

106.87%

-2.26M

2023Q4

602

52.89M

106.58%

-3.51M

2023Q3

590

52.77M

106.53%

-2.81M

2023Q2

589

51.93M

104.86%

-4.95M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

7.03M

14.28%

-239.29K

-3.29%

Jun 30, 2025

The Vanguard Group, Inc.

5.62M

11.42%

-2.89K

-0.05%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

2.47M

5.02%

-244.43K

-9.00%

Jun 30, 2025

Ariel Investments, LLC

2.20M

4.47%

-316.61K

-12.57%

Jun 30, 2025

State Street Investment Management (US)

2.00M

4.06%

+1.65K

+0.08%

Jun 30, 2025

Macquarie Investment Management

1.97M

4%

-285.27K

-12.66%

Jun 30, 2025

Kayne Anderson Rudnick Investment Management, LLC

1.75M

3.55%

+168.12K

+10.64%

Jun 30, 2025

Allspring Global Investments, LLC

1.52M

3.09%

-94.00K

-5.82%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.41M

2.87%

+9.46K

+0.67%

Jun 30, 2025

Goldman Sachs Asset Management, L.P.

949.09K

1.93%

+534.84K

+129.11%

Jun 30, 2025

持股ETF



更新时间: 11月6日周四

机构名称

占比

Invesco Pharmaceuticals ETF

2.51%

Schwab Ariel Opportunities ETF

2.33%

SPDR S&P Pharmaceuticals ETF

2.31%

Invesco S&P SmallCap Health Care ETF

1.95%

Congress SMid Growth ETF

1.92%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

1.73%

iShares U.S. Pharmaceuticals ETF

1.13%

Brandes US Small-Mid Cap Value ETF

0.86%

JPMorgan Active Small Cap Value ETF

0.72%

Invesco S&P SmallCap Low Volatility ETF

0.63%

Invesco Pharmaceuticals ETF

占比2.51%

Schwab Ariel Opportunities ETF

占比2.33%

SPDR S&P Pharmaceuticals ETF

占比2.31%

Invesco S&P SmallCap Health Care ETF

占比1.95%

Congress SMid Growth ETF

占比1.92%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

占比1.73%

iShares U.S. Pharmaceuticals ETF

占比1.13%

Brandes US Small-Mid Cap Value ETF

占比0.86%

JPMorgan Active Small Cap Value ETF

占比0.72%

Invesco S&P SmallCap Low Volatility ETF

占比0.63%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据